AstraZeneca vaccine comes to Kosovo today, this is information you need to know about it.

The first vaccined contingent in Kosovo arrives on the evening of March 28th and is within the vaccine Kosovo will receive free of charge from the World Health Organisation's programme COVAX (OBSH).

At the end of last year, the United Kingdom became the first state to adopt AstraZeneca vaccine, given through two doses.

So far, this vaccine has been approved for use in over 70 countries worldwide, including the European drug regulator.

Also, WHO has recommended the use of this vaccine.

Efficiency

AstraZeneca vaccine contains weakened virus, which is used to create vaccines for common flu.

This virus aims to provide instructions on the creation of proteins that will help the immune system fight and prevent coronary infection.

Since AstraZeneca reported on the development of its vaccine against coronary, it has also attributed its efficiency against COVID-19 disease.

But according to a recent study conducted in the United States, attended by 32,449 volunteers, the vaccine was 79 percent effective in preventing COVID-19 symptoms.

Meanwhile, according to this study, conducted by an independent panel, this vaccine was 100 percent effective with COVID-19 and cases of hospitalization.

This vaccine is administered in individuals over 18.

The two doses of AstraZenecas vaccine are given between four and 12 weeks.

According to some studies, the longer the period between the first and the second dosage, the higher the immunity that vaccines create.

Because of the free price, AstraZenecia vaccine has become accessible to many countries in the world. The price for this vaccine ranges between $3 and $15.

Blood Oppression

In early March of this year, some states suspended the use of AstraZenecsa vaccine because of the side effects of this vaccine, some individuals have had blood clots respectively after accepting the vaccine.

But on March 18th, the European Barnat Agency said that the use of AstraZenecas vaccine is safe, despite reports of blood clotting, Rel reports.

According to the European regulator, the benefits of this vaccine exceed the risks.

Over 65 years of age

In clinical studies conducted in the development of AstraZeneca vaccine, very few people over 65 have been involved.

Despite this, the World Health Organization has recommended that this vaccine be given to this age group, saying that the efficiency of the vaccine in this age group is widespread.

The more accurate assessments of efficiency for this age group are expected soon, both from the evidence under way, but also from the studies on efficiency that the countries are using this vaccine. The immune answers caused by vaccines in older people are well documented and similar in other age groups. This suggests that vaccines are likely to be effective in older people as well.

Evidence data says the vaccine is secure for this age group”, said the WHO assessment published in February of this year.

COVID's most contagious varieties are, in effect, two new versions of the Coronavirus, believed to be more contagious: the one originally discovered in the United Kingdom and the one in South Africa.

According to WHO estimates, AstraZeneca vaccine has shown less efficiency towards these variants. For the U.K. version, WHO has said that from preliminary results, the AstraZeneca vaccine is accompanied by lowering the production of antibodies.

In the meantime, for South Africa's variant, this vaccine is less effective with moderate and mild illnesses and has had less production of antibodies.

Unlike Pfizer Company vaccines/ B ONTech and Moderna, seeking to be stored at ultra-low temperatures, AstraZeneca vaccine can be stored in normal refrigerators at temperatures of between 2 and 8 degrees Celsius.